Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$606K Sell
11,353
-4,134
-27% -$207K 0.09% 379
2017
Q2
$753K Sell
15,487
-19,467
-56% -$881K 0.11% 334
2017
Q1
$1.55M Buy
34,954
+26,325
+305% +$1.14M 0.3% 95
2016
Q4
$331K Buy
8,629
+2,143
+33% +$85K 0.08% 407
2016
Q3
$274K Buy
+6,486
New +$278K 0.06% 465
2016
Q1
Sell
-11,297
Closed -$507K 614
2015
Q4
$507K Sell
11,297
-21,342
-65% -$942K 0.14% 291
2015
Q3
$1.31M Sell
32,639
-30,451
-48% -$1.44M 0.3% 87
2015
Q2
$3.1M Sell
63,090
-36,992
-37% -$1.78M 0.39% 91
2015
Q1
$4.64M Buy
100,082
+34,999
+54% +$1.61M 0.64% 17
2014
Q4
$2.93M Buy
+65,083
New +$2.84M 0.59% 27

Other funds holding ABT

GAM Systematic's ABT Position: Q3 2017 in Review

GAM Systematic reduced its Abbott (ABT) stake by 27% in Q3 2017, selling an estimated $207K and leaving 11,353 shares worth $606K. The position accounts for 0.09% of the portfolio, ranked #379.

GAM Systematic first reported a position in ABT in Q4 2014 and has held it in 10 quarters since. The position peaked at $4.64M in Q1 2015. 1,597 funds tracked by Wall St. Rank hold ABT as of Q3 2017.

  • GAM Systematic held 11,353 shares of Abbott worth $606K as of Q3 2017.
  • GAM Systematic sold 4,134 Abbott shares in Q3 2017, an estimated $207K.
  • Abbott made up 0.09% of GAM Systematic's portfolio in Q3 2017, its #379 holding.
  • GAM Systematic first reported a position in Abbott in Q4 2014 and has held it in 10 quarters since.
  • GAM Systematic's Abbott position peaked at $4.64M in Q1 2015.
  • 1,597 funds tracked by Wall St. Rank held Abbott as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.